Mereo BioPharma Group plc (MREO): Total Assets
$45.92M
As of 2025-12-31
$34.71M
As of 2026-06-30
-16.0%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $45.92M | -39.9% | 2026-03-19, Balance as of period end |
| 2024-12-31 | $76.39M | +14.9% | 2026-03-19, Balance as of period end |
| 2023-12-31 | $66.50M | -14.1% | 2025-03-26, Balance as of period end |
| 2022-12-31 | $77.41M | n/a | 2024-03-27, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $45.92M | -39.9% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $2.67M | -25.3% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $5.33M | -60.5% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $131.44M | -35.1% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $30.16M | -54.9% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $84.18M | -19.7% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $12.87M | +43.1% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $2.60M | -28.5% |
| Medicinova Inc (MNOV) | 2025-12-31 | $45.60M | -18.4% |
Compare MREO, LIPO, QUCY, SLN side by side · Screen every company in Pharmaceutical Preparations ↗